Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
AMGN Amgen Inc. daily Stock Chart
AMGN [NASD]
Amgen Inc.
Healthcare | Biotechnology | USA
statements
IndexS&P 500 P/E18.04 EPS (ttm)13.03 Insider Own0.10% Shs Outstand597.15M Perf Week-2.76%
Market Cap140.35B Forward P/E14.63 EPS next Y16.06 Insider Trans-6.28% Shs Float592.90M Perf Month-3.30%
Income8.07B PEG2.28 EPS next Q3.52 Inst Own79.80% Short Float1.67% Perf Quarter14.75%
Sales23.40B P/S6.00 EPS this Y14.80% Inst Trans0.30% Short Ratio4.48 Perf Half Y33.72%
Book/sh18.24 P/B12.89 EPS next Y9.27% ROA12.90% Target Price237.00 Perf Year16.61%
Cash/sh34.92 P/C6.73 EPS next 5Y7.90% ROE71.60% 52W Range166.30 - 244.99 Perf YTD-2.50%
Dividend6.40 P/FCF24.68 EPS past 5Y13.70% ROI19.80% 52W High-4.06% Beta1.11
Dividend %2.72% Quick Ratio2.60 Sales past 5Y4.90% Gross Margin82.10% 52W Low41.33% ATR3.54
Employees21500 Current Ratio2.90 Sales Q/Q-2.80% Oper. Margin42.80% RSI (14)42.37 Volatility1.65% 1.39%
OptionableYes Debt/Eq2.73 EPS Q/Q14.10% Profit Margin34.50% Rel Volume0.94 Prev Close236.75
ShortableYes LT Debt/Eq2.54 EarningsJan 28 AMC Payout43.30% Avg Volume2.21M Price235.04
Recom2.20 SMA20-2.01% SMA500.10% SMA20017.36% Volume2,083,411 Change-0.72%
Jan-21-20Upgrade Evercore ISI In-line → Outperform
Dec-24-19Initiated Raymond James Mkt Perform
Dec-17-19Resumed Morgan Stanley Overweight $280
Nov-12-19Initiated SunTrust Buy $256
Nov-05-19Upgrade Cantor Fitzgerald Neutral → Overweight $230 → $255
Oct-17-19Resumed BofA/Merrill Neutral $215
Aug-19-19Downgrade Mizuho Buy → Neutral $208 → $212
May-23-19Upgrade Citigroup Neutral → Buy
May-21-19Initiated Credit Suisse Outperform $208
Jan-28-19Downgrade Evercore ISI Outperform → In-line
Oct-01-18Initiated Cantor Fitzgerald Neutral $223
Apr-05-18Reiterated Barclays Equal Weight $190 → $180
Feb-12-18Reiterated Mizuho Buy $192 → $200
Jan-23-18Upgrade Argus Hold → Buy
Nov-01-17Downgrade Argus Buy → Hold
Oct-26-17Reiterated RBC Capital Mkts Sector Perform $192 → $188
Sep-28-17Reiterated Mizuho Buy $183 → $198
Sep-15-17Initiated RBC Capital Mkts Sector Perform $192
Jul-11-17Resumed Jefferies Buy
Jun-23-17Initiated Deutsche Bank Hold $172
Jan-23-20 12:31PM  Amgen (AMGN) Reports Next Week: Wall Street Expects Earnings Growth Zacks
10:39AM  Amgen Stock Is Poised to Gain in 2020, Analyst Says. Heres Why. Barrons.com
Jan-22-20 09:20AM  5 Big Drug/Biotech Stocks Set to Trump Q4 Earnings Estimates Zacks
09:13AM  Should First Trust Capital Strength ETF (FTCS) Be on Your Investing Radar? Zacks
09:00AM  Free "LabXchange" Science Education Accelerator Launched By Amgen Foundation And Harvard's Faculty Of Arts And Sciences PR Newswire
Jan-21-20 06:13PM  Roche's (RHHBY) Lymphoma Drug Polivy Gets Approval in Europe Zacks
Jan-20-20 03:25PM  Top Stock Reports for Alphabet, JPMorgan & Comcast Zacks
Jan-16-20 09:55AM  Should Value Investors Consider Amgen (AMGN) Stock Now? Zacks
05:00AM  Top Picks 2020- Amgen AMGN MoneyShow
Jan-14-20 01:01PM  Amgen Inc. -- Moody's announces completion of a periodic review of ratings of Amgen Inc. Moody's
09:55AM  Biogen Acquires Early-Stage CNS Drug From Pfizer for $75M Zacks
07:55AM  The Daily Biotech Pulse: PhaseBio To Buy Hypertension Asset, Stemline Falls On Q4 Pre-Announcement, FDA Panel To Review Nektar's Opioid Drug Benzinga
Jan-13-20 04:20PM  Amgen Announces Global Diagnostic Collaborations To Expand Molecular Testing For Patients With Non-Small Cell Lung Cancer PR Newswire
10:13AM  Know These 3 Facts to Avoid Paying Half Your Retirement Income to the IRS - January 13, 2020 Zacks
Jan-10-20 10:00AM  Bet on Favorite Sector ETFs & Stocks This Earnings Season Zacks
Jan-09-20 04:00PM  Amgen To Present At The 38th Annual J.P. Morgan Healthcare Conference PR Newswire
08:43AM  Merck's Keytruda Gets FDA Nod for High-Risk Bladder Cancer Zacks
Jan-08-20 07:48AM  Apellis' (APLS) PNH Drug Betters Alexion's Soliris in Study Zacks
Jan-07-20 04:00PM  Amgen To Present At The Goldman Sachs 12th Annual Healthcare CEOs Unscripted Conference PR Newswire
10:26AM  Waltham biotech's drug bests Alexion's blockbuster Soliris in new trial American City Business Journals
10:02AM  Merck's Keytruda Misses One of Two Goals in Lung Cancer Study Zacks
09:00AM  The Biggest Biotech Just Touched A Record High Is Amgen Stock A Buy? Investor's Business Daily
Jan-06-20 12:10PM  Why Amgen (AMGN) is Poised to Beat Earnings Estimates Again Zacks
08:23AM  Amgen Stock Up in a Year on Pipeline & Biosimilar Progress Zacks
Jan-03-20 02:11PM  Cash-strapped biotech signs deal with Chinese drugmaker BeiGene American City Business Journals
Jan-02-20 09:49AM  4 Reasons Why Investors Should Buy Alexion (ALXN) in 2020 Zacks
08:15AM  BeiGene Announces Closing of Amgen Global Strategic Oncology Collaboration and Equity Investment GlobeNewswire
08:15AM  Amgen Commences Strategic Collaboration With BeiGene to Expand Oncology Presence in China PR Newswire
Jan-01-20 12:00PM  Amgen (AMGN) Upgraded to Buy: Here's What You Should Know Zacks
Dec-31-19 12:01PM  Vascepas Future Looks Rosy, But It Could Still Be Fishy for Amarin Stock InvestorPlace
08:22AM  Heres Why Amarin Stock Slumped Despite the FDA Approval InvestorPlace
Dec-27-19 01:36PM  U.S. Cannabis Stocks Will Make Cheap, Smart Buys in 2020 InvestorPlace
10:42AM  Roche and Gilead Losing Patent Protection on Top Sellers GuruFocus.com
Dec-26-19 01:37PM  Spectrum Pharmaceuticals shares slide 57% after lung cancer trial misses goals MarketWatch
Dec-25-19 08:20PM  How Did Amgen, Inc. (AMGN) Compare Against Top Hedge Fund Stocks in 2019? Insider Monkey
Dec-24-19 09:03AM  What to Expect from Amgen and Regeneron Stock in 2020, According to an Analyst Barrons.com
Dec-23-19 04:12PM  Pharma M&A Deals Likely To Be Smaller in 2020 GuruFocus.com
Dec-21-19 11:08AM  Amarins fish-oil pill is now available to millions more patients, but its still no Lipitor MarketWatch
Dec-20-19 09:30AM  3 Investing Facts About Required Minimum Distributions You Need to Know - December 20, 2019 Zacks
08:12AM  The Daily Biotech Pulse: Axovant Surges On Gene Therapy Study Results, FDA Approves Merck's Ebola Vaccine, Abeona Announces Offering Benzinga
04:02AM  Troubled Traders Investopedia
Dec-19-19 04:44PM  Amgen And Allergan Submit Biologics License Application For ABP 798, Biosimilar Candidate To Rituxan® (rituximab), To U.S. Food And Drug Administration PR Newswire
10:13AM  The Zacks Analyst Blog Highlights: Amarin, Amgen, Gilead Sciences, Biogen and Kiniksa Pharmaceuticals Zacks
10:01AM  AbbVie's JAK Inhibitor Rinvoq Receives Approval for RA in EU Zacks
Dec-18-19 05:50PM  Amgen (AMGN) Dips More Than Broader Markets: What You Should Know Zacks
02:27PM  Biotech Stock Roundup: AMRN Stock Up, Pipeline Updates from GILD, BIIB, AMGN & More Zacks
11:08AM  The Zacks Analyst Blog Highlights: Apple, Cisco Systems, Oracle, HSBC and Amgen Zacks
Dec-17-19 06:27PM  8 Biotech Stocks Morgan Stanley Recommends For 2020 Benzinga
03:23PM  Top Analyst Reports for Apple, Cisco & Oracle Zacks
07:56AM  The Daily Biotech Pulse: Roche Gets US Antitrust Clearance For Spark Purchase, An Orphan Drug Designation For Prevail, Dynavax Names CEO Benzinga
Dec-16-19 04:54PM  Goldman Sachs bullish on the healthcare sector Yahoo Finance Video
02:26PM  Goldman Sachs Adds Amgen, UnitedHealth, Dentsply Sirona To Conviction List Benzinga
01:38PM  Amarins Vascepa Approval Seems Fishy for Patients and AMRN Investors InvestorPlace
11:51AM  Amgen Stock Rises 3% Investing.com
10:15AM  3 Health-Care Stocks Goldman Sachs Says to Buy Barrons.com
08:38AM  Amarin Gains on FDA Approval of Vascepa Label Expansion Zacks
07:01AM  Amgen, UnitedHealth and Dentsply Higher After Goldman Adds Them to Conviction List TheStreet.com
Dec-13-19 04:07PM  Investors Are Heavily Buying These 19 Stocks Investor's Business Daily
08:10AM  The Daily Biotech Pulse: Second Time's The Charm For Sarepta, Pfizer's Xeljanz Snags Third Approval, NewLink Genetics Rejects Competing Offer Benzinga
Dec-12-19 09:36AM  Amgen's Osteoporosis Drug Evenity Gets Approval in Europe Zacks
07:38AM  The Daily Biotech Pulse: European Nod For Amgen, miRagen Overhauls Clinical Pipeline, Tonix Snags Patent Win Benzinga
01:00AM  European Commission Approves EVENITY® (romosozumab) For The Treatment Of Severe Osteoporosis In Postmenopausal Women At High Risk Of Fracture PR Newswire
Dec-11-19 05:45PM  Amgen (AMGN) Gains But Lags Market: What You Should Know Zacks
04:18PM  Amgen board hikes dividend by 10% MarketWatch
04:00PM  Amgen Announces 10% Increase In 2020 First Quarter Dividend PR Newswire
09:41AM  Biotech Stock Roundup: ASH Data in Focus, Amgen Gets FDA Nod to Remicade Biosimilar Zacks
Dec-10-19 10:10AM  Biotech ETFs Hit New Highs on Deal Activities Zacks
09:02AM  Healthpeak Amends & Extends Lease With Amgen in San Francisco Zacks
07:30AM  Amgen Data From Phase 3 CANDOR Study Combining KYPROLIS® (carfilzomib) And DARZALEX® (daratumumab) To Be Presented During Late-Breaking Session At American Society Of Hematology Annual Meeting PR Newswire
Dec-09-19 09:01PM  Stocks Hold Against Resistance Investopedia
04:00PM  Beyond Cholesterol: Landmark deCODE Study Elucidates Role of Lipoprotein(a) as Major Risk Factor for Heart Disease PR Newswire
10:03AM  World's largest biotech company to move up to BioMed's big South City project American City Business Journals
09:02AM  Amgen Gets FDA Approval for J&J/Merck's Remicade Biosimilar Zacks
09:00AM  Amgen Selects Location For R&D Facility In The South San Francisco Biotechnology Hub PR Newswire
Dec-07-19 08:35AM  The Week Ahead In Biotech: ASH Presentations Pick Up Steam, Correvio Awaits Adcom Ruling Benzinga
Dec-06-19 02:31PM  FDA Approves Amgen's AVSOLA (infliximab-axxq), For The Same Indications As Remicade® (infliximab) PR Newswire
12:34PM  UPDATE 1-FDA approves Amgen's biosimilar to J&J's rheumatoid arthritis drug Reuters
12:09PM  FDA approves Amgen's biosimilar to J&J's rheumatoid arthritis drug Reuters
10:22AM  Money Is Moving Back Into Surging Biotech Funds Barrons.com
09:30AM  Biogen Up on New Data on Alzheimer's Candidate Aducanumab Zacks
Dec-03-19 06:57PM  Hanging On: Stocks Catch Support Investopedia
02:01PM  Pharmacy benefits manager Abarca inks discount deal for Amgen's Enbrel Reuters
11:22AM  Cramer Weighs In On Biogen, Caterpillar And More Benzinga
09:29AM  Biogen's Shares Down on Rating Downgrade by Baird Analyst Zacks
09:26AM  Where to Buy Booming Biotech ETFs Investopedia
09:24AM  Merck's Keytruda Gets FDA's Priority Tag in Bladder Cancer Zacks
09:24AM  Amgen Gets Shot in the Arm, Could Bounce Up in Months Ahead TheStreet.com
09:10AM  Abarca, Amgen Enter Outcome-Based Agreement For Enbrel PR Newswire
Dec-02-19 04:00PM  Amgen Announces Data Being Presented At ASH 2019 PR Newswire
11:00AM  Looking For Growth? Take A Look At These Biotechnology Stocks Investor's Business Daily
07:00AM  Heart Drugs Are Having a Moment Bloomberg
Nov-29-19 11:24AM  The Zacks Analyst Blog Highlights: Intercept, CymaBay, Amgen, Global Blood Therapeutics and ChemoCentryx Zacks
08:13AM  Attention Biotech Investors: Mark Your Calendar For These December PDUFA Dates Benzinga
Nov-28-19 10:33PM  Were Hedge Funds Right About Warming Up To Amgen, Inc. (AMGN)? Insider Monkey
09:31AM  Amgen (AMGN) Up 11.2% Since Last Earnings Report: Can It Continue? Zacks
08:44AM  Here's Why Merck's (MRK) Shares Are Up This Year Zacks
Nov-27-19 10:12AM  Merck's Keytruda Gets Nod in China for Difficult Lung Cancer Zacks
10:09AM  Biotech Stock Roundup: CBAY Falls, CCXI Gains, Amgen Acquires Otezla & More Zacks
Nov-26-19 05:54PM  BeiGene Shares Climb Nearly 50% After Amgen Deal GuruFocus.com
07:19AM  Novartis Securities Investment Ltd -- Moody's affirms Novartis' A1 rating; stable outlook Moody's
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It offers products for the treatment of oncology/hematology, cardiovascular, inflammation, bone health, and neuroscience. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta, a pegylated protein to treat cancer patients; Prolia to treat postmenopausal women with osteoporosis; Aranesp to treat anemia; Xgeva for skeletal-related events prevention; Sensipar/Mimpara products to treat sHPT in chronic kidney disease; and EPOGEN to treat a lower-than-normal number of red blood cells. It also markets other products in various markets, including Kyprolis, Nplate, Vectibix, Repatha, NEUPOGEN, Parsabiv, Blincyto, Aimovig, Imlygic, Corlanor, Kanjintitm, and Amgevitatm. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaborative agreements with Novartis; UCB; Bayer HealthCare Pharmaceuticals Inc.; Syapse; DaVita Inc.; BeiGene, Ltd.; and QIAGEN N.V., as well as strategic research partnership with the University of Washington's Institute for Protein Design. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Meline David WEVP & CFONov 25Sale234.368,7372,047,60349,378Nov 25 06:27 PM
Graham Jonathan PEVP, Gen. Counsel & Secy.Nov 22Sale230.549,0002,074,83742,853Nov 25 06:25 PM
Piacquad DavidSVP, Business DevelopmentNov 20Option Exercise156.355,749898,85653,361Nov 20 08:09 PM
SUGAR RONALD DDirectorNov 06Option Exercise54.712,000109,42016,436Nov 07 06:20 PM
Williams R SandersDirectorNov 06Sale215.4542591,5665,413Nov 07 06:22 PM
SUGAR RONALD DDirectorNov 06Sale215.452,000430,90014,436Nov 07 06:20 PM
SUGAR RONALD DDirectorOct 02Option Exercise54.712,000109,42016,436Oct 03 05:06 PM
SUGAR RONALD DDirectorOct 02Sale193.582,000387,16014,436Oct 03 05:06 PM
SUGAR RONALD DDirectorSep 04Option Exercise54.712,000109,42016,336Sep 04 06:08 PM
SUGAR RONALD DDirectorSep 04Sale206.702,000413,40014,336Sep 04 06:08 PM
Patton Cynthia MSVP & CCOAug 30Option Exercise158.438,6241,366,33132,648Sep 04 06:07 PM
Patton Cynthia MSVP & CCOAug 30Sale208.0713,4262,793,51022,097Sep 04 06:07 PM
SUGAR RONALD DDirectorAug 07Option Exercise54.712,000109,42016,336Aug 08 07:09 PM
Williams R SandersDirectorAug 07Sale183.0442577,7925,838Aug 08 07:12 PM
SUGAR RONALD DDirectorAug 07Sale183.042,000366,08014,336Aug 08 07:09 PM
SUGAR RONALD DDirectorJul 03Option Exercise54.712,000109,42016,336Jul 08 04:23 PM
SUGAR RONALD DDirectorJul 03Sale187.582,000375,16014,336Jul 08 04:23 PM
SUGAR RONALD DDirectorJun 05Option Exercise54.712,000109,42016,219Jun 05 06:55 PM
SUGAR RONALD DDirectorJun 05Sale175.682,000351,36014,219Jun 05 06:55 PM
SUGAR RONALD DDirectorMay 01Option Exercise54.712,000109,42015,092May 03 05:37 PM
SUGAR RONALD DDirectorMay 01Sale175.732,000351,46013,092May 03 05:37 PM
SUGAR RONALD DDirectorApr 03Option Exercise54.712,000109,42015,092Apr 03 06:27 PM
SUGAR RONALD DDirectorApr 03Sale193.182,000386,36013,092Apr 03 06:27 PM
SUGAR RONALD DDirectorMar 06Option Exercise54.712,000109,42014,988Mar 08 07:47 PM
SUGAR RONALD DDirectorMar 06Sale188.882,000377,76012,988Mar 08 07:47 PM
SUGAR RONALD DDirectorFeb 07Option Exercise54.712,000109,42014,988Feb 11 09:27 PM
SUGAR RONALD DDirectorFeb 07Sale190.002,000380,00012,988Feb 11 09:27 PM
open in yahoo | open in reuters | open in google